COVID-19 Resource Center

COVID-19 Resource Center

Source: John A. Hovanesian, MD, FACS, and Jim Mazzo

Disclosures: Hovanesian reports a financial interest in 1-800-DOCTORS, Acufocus, Aerie, Alcon, Allegro, Allergan, BlephEx, Cord, Eyedetec, Glaukos, Guardion, Johnson & Johnson Vision, Katena, Ivantis, Kala, MDbackline, Novartis, Ocular Therapeutix, Omeros, Sarentis Ophthalmics, Sensimed, Tear Film Innovations and Valeant. Mazzo reports a financial interest in Avellino Labs, Carl Zeiss Meditec, Centricity, IanTech, LensGen, Neurotech, ReFocus and Visus.
September 04, 2020
1 min watch
Save

VIDEO: Hovanesian interviews Mazzo on ophthalmology's future in coronavirus era, part 4

Source: John A. Hovanesian, MD, FACS, and Jim Mazzo

Disclosures: Hovanesian reports a financial interest in 1-800-DOCTORS, Acufocus, Aerie, Alcon, Allegro, Allergan, BlephEx, Cord, Eyedetec, Glaukos, Guardion, Johnson & Johnson Vision, Katena, Ivantis, Kala, MDbackline, Novartis, Ocular Therapeutix, Omeros, Sarentis Ophthalmics, Sensimed, Tear Film Innovations and Valeant. Mazzo reports a financial interest in Avellino Labs, Carl Zeiss Meditec, Centricity, IanTech, LensGen, Neurotech, ReFocus and Visus.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, and ophthalmic industry veteran Jim Mazzo discuss the changes taking place in the ophthalmic industry and physician practices in the coronavirus pandemic era.

In this installment, they discuss the recent surge in elective surgeries and whether that will be a long-term trend or a short-term burst from the lockdown, as well as challenges in re-staffing ophthalmic practices and how to become more efficient practitioners.